BiotechTube
Home/Isofol Medical/Petter Segelman Lindqvist
PS

Petter Segelman Lindqvist

Chief Executive Officer

Isofol Medical

Therapeutic Areas

OncologyNeurology

Isofol Medical Pipeline

DrugIndicationPhase
ArfolitixorinMetastatic Colorectal Cancer (mCRC)Phase Ib/II

Leadership Team at Isofol Medical

SS
Sebastian Stintzing
Principal Coordinating Investigator (External KOL)
View full Isofol Medical profile